Adagene (ADAG) Revenue & Revenue Breakdown
Adagene Revenue Highlights
Latest Revenue (Y)
$18.11M
Latest Revenue (Q)
$833.34K
Main Segment (Y)
Service
Main Geography (Y)
Service
Adagene Revenue by Period
Adagene Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $18.11M | 94.90% |
| 2022-12-31 | $9.29M | -8.67% |
| 2021-12-31 | $10.18M | 2019.85% |
| 2020-12-31 | $480.00K | - |
| 2019-12-31 | $480.00K | -68.24% |
| 2018-12-31 | $1.51M | - |
Adagene generated $18.11M in revenue during NA 2023, up 94.90% compared to the previous quarter, and up 1198.51% compared to the same period a year ago.
Adagene Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $833.34K | 104.31% |
| 2023-09-30 | $407.87K | -97.64% |
| 2023-06-30 | $17.30M | 100.00% |
| 2023-03-31 | $8.65M | 55.31% |
| 2022-12-31 | $5.57M | 107.40% |
| 2022-09-30 | $2.68M | -31.57% |
| 2022-06-30 | $3.92M | -57.83% |
| 2021-12-31 | $9.30M | 5356.65% |
| 2020-12-31 | $170.50K | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2019-12-31 | $480.00K | - |
Adagene generated $833.34K in revenue during Q4 2023, up 104.31% compared to the previous quarter, and up 31.04% compared to the same period a year ago.
Adagene Revenue Breakdown
Adagene Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 |
|---|---|
| License | $225.00K |
| Service | $398.88K |
Adagene's latest annual revenue breakdown by segment (product or service), as of Dec 20: Service (63.94%), and License (36.06%).
Adagene Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| License | $225.00K |
| Service | $398.88K |
Adagene's latest annual revenue breakdown by geography, as of Dec 20: Service (63.94%), and License (36.06%).
Adagene Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $10.97M |
| JANX | Janux Therapeutics | $8.08M | $1.25M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| MLYS | Mineralys Therapeutics | - | - |
ADAG Revenue FAQ
What is Adagene’s yearly revenue?
Adagene's yearly revenue for 2023 was $18.11M, representing an increase of 94.90% compared to 2022. The company's yearly revenue for 2022 was $9.29M, representing a decrease of -8.67% compared to 2021. ADAG's yearly revenue for 2021 was $10.18M, representing an increase of 2019.85% compared to 2020.
What is Adagene’s quarterly revenue?
Adagene's quarterly revenue for Q4 2023 was $833.34K, a 104.31% increase from the previous quarter (Q3 2023), and a -85.03% decrease year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $407.87K, a -97.64% decrease from the previous quarter (Q2 2023), and a -84.81% decrease year-over-year (Q3 2022). ADAG's quarterly revenue for Q2 2023 was $17.3M, a 100.00% increase from the previous quarter (Q1 2023), and a 340.86% increase year-over-year (Q2 2022).
What is Adagene’s revenue growth rate?
Adagene's revenue growth rate for the last 3 years (2021-2023) was 78.00%, and for the last 5 years (2019-2023) was 3673.23%.
What are Adagene’s revenue streams?
Adagene's revenue streams in c 20 are License, and Service. License generated $225K in revenue, accounting 36.06% of the company's total revenue Service generated $398.88K in revenue, accounting 63.94% of the company's total revenue
What is Adagene’s main source of revenue?
For the fiscal year ending Dec 20, the largest source of revenue of Adagene was Service. This segment made a revenue of $398.88K, representing 63.94% of the company's total revenue.